Investeringsoversigt

7775 Investeringer

Titel Sortér faldende	Periode	Program
Development of a translational rat model of non-alcoholic steatohepatitis (NASH) with liver fibrosis	2021 - 2023	Erhvervsforsker
Development of a translational rat model of non-alcoholic steatohepatitis (NASH) with liver fibrosis Periode 2021 - 2023 Region Region Hovedstaden Program Erhvervsforsker Fagområde Biotek, Medico og Sundhed Investering Percentage 100 Fondens investering 1,1 mio. Samlet budget 1,1 mio. Projektdeltagere University of Copenhagen, GUBRA ApS Projektleder GUBRA ApS Læs mere om projektet
Development of advanced interconnects for solid oxide cell stacks.	2020 - 2023	Erhvervsforsker
Development of advanced interconnects for solid oxide cell stacks. Periode 2020 - 2023 Region Region Hovedstaden Program Erhvervsforsker Fagområde Energi, Klima og Miljø Investering Percentage 100 Fondens investering 1,1 mio. Samlet budget 1,1 mio. Projektdeltagere Technical University of Denmark, Topsoe A/S Projektleder Topsoe A/S Læs mere om projektet
Development of advanced maritime cyber security: MUNINN Maritime (M2)	2019 - 2020	Innobooster
Development of advanced maritime cyber security: MUNINN Maritime (M2) Periode 2019 - 2020 Region Region Hovedstaden Program Innobooster Fagområde Ikke defineret Investering Percentage 33 Fondens investering 594.000 Samlet budget 1,8 mio. Projektdeltagere Wehowsky.com ApS Projektleder Muninn ApS Læs mere om projektet
Development of an 131I-labeled FAP targeting radiopharmaceutical to treat triple negative breast cancer	2024 - 2026	Erhvervsforsker
Development of an 131I-labeled FAP targeting radiopharmaceutical to treat triple negative breast cancer Periode 2024 - 2026 Region Program Erhvervsforsker Fagområde Ikke defineret Investering Percentage 40.89 Fondens investering 828.000 Samlet budget 2,0 mio. Triple-negative breast cancer represents 15-20% of breast cancers and it is the most challenging sub-type to treat. There is currently no good treatment for TNBC. Patients with TNBC have a much shorter survival period once distant metastases have occurred. In this project, we will develop a therapeutic radiopharmaceutical (RP) that targets TNBC, including its metastases, and irradiates it. Our drug will be based on a fibroblast activation protein targeting moiety radiolabeled with iodine-131. Projektdeltagere University of Copenhagen, Tetrakit Technologies ApS Projektleder Læs mere om projektet
Development of an immune modulating cancer vaccine targeting CCL22	2020 - 2023	Erhvervsforsker
Development of an immune modulating cancer vaccine targeting CCL22 Periode 2020 - 2023 Region Region Hovedstaden Program Erhvervsforsker Fagområde Biotek, Medico og Sundhed Investering Percentage 36.05 Fondens investering 1,1 mio. Samlet budget 3,0 mio. Projektdeltagere University of Copenhagen, IO BIOTECH ApS Projektleder IO BIOTECH ApS Læs mere om projektet
Development of analytical application by direct spectroscopy (FTIR: NIR: UV-VIS) for optimizing red wine production in regard to the phenolic composition	2017 - 2020	Erhvervsforsker
Development of analytical application by direct spectroscopy (FTIR: NIR: UV-VIS) for optimizing red wine production in regard to the phenolic composition Periode 2017 - 2020 Region Region Hovedstaden Program Erhvervsforsker Fagområde Produktion, Materialer, Digitalisering og IKT Investering Percentage 58.79 Fondens investering 1,3 mio. Samlet budget 2,2 mio. Projektdeltagere FOSS ANALYTICAL A/S Projektleder FOSS ANALYTICAL A/S Læs mere om projektet
Development of antibody for cancer treatment that specifically depletes an immune supresive subset of tumor associated macrophages	2023 - 2024	Innobooster
Development of antibody for cancer treatment that specifically depletes an immune supresive subset of tumor associated macrophages Periode 2023 - 2024 Region Program Innobooster Fagområde Ikke defineret Investering Percentage 35 Fondens investering 338.529 Samlet budget 967.225 Projektdeltagere OncoSpear ApS Projektleder Læs mere om projektet
Development of Aquaporin Inside™ technology for Osmotic Membrane Bioreactors	2018 - 2021	Erhvervsforsker
Development of Aquaporin Inside™ technology for Osmotic Membrane Bioreactors Periode 2018 - 2021 Region Region Hovedstaden Program Erhvervsforsker Fagområde Energi, Klima og Miljø Investering Percentage 56.3 Fondens investering 1,1 mio. Samlet budget 1,9 mio. Projektdeltagere Technical University of Denmark, AQUAPORIN A/S Projektleder AQUAPORIN A/S Læs mere om projektet
Development of Clinical Applications for Evosep One	2021 - 2023	Erhvervsforsker
Development of Clinical Applications for Evosep One Periode 2021 - 2023 Region Region Syddanmark Program Erhvervsforsker Fagområde Biotek, Medico og Sundhed Investering Percentage 100 Fondens investering 1,2 mio. Samlet budget 1,2 mio. Projektdeltagere University of Southern Denmark, Evosep ApS Projektleder Evosep ApS Læs mere om projektet
Development of Compatibilized Graphene for Enhanced Material Properties	2020 - 2022	Erhvervsforsker
Development of Compatibilized Graphene for Enhanced Material Properties Periode 2020 - 2022 Region Region Syddanmark Program Erhvervsforsker Fagområde Produktion, Materialer, Digitalisering og IKT Investering Percentage 100 Fondens investering 862.500 Samlet budget 862.500 Projektdeltagere Aarhus University, Danish Graphene ApS Projektleder Danish Graphene ApS Læs mere om projektet
Development of controlled atmosphere (CA)-reefer banana ripening technology for ripening of banana fruit during shipping (ReefRipeCA)	2019 - 2020	Erhvervsforsker
Development of controlled atmosphere (CA)-reefer banana ripening technology for ripening of banana fruit during shipping (ReefRipeCA) Periode 2019 - 2020 Region Region Syddanmark Program Erhvervsforsker Fagområde Bioressourcer, Fødevarer og Livsstil Investering Percentage 8.34 Fondens investering 828.000 Samlet budget 9,9 mio. Projektdeltagere Aarhus University, MAERSK CONTAINER INDUSTRY A/S Projektleder MAERSK CONTAINER INDUSTRY A/S Læs mere om projektet
Development of Cost-Effective High-Energy Product NdFeB Permanent Magnets by Partial Substitution of La and Ce	2020 - 2023	Erhvervsforsker
Development of Cost-Effective High-Energy Product NdFeB Permanent Magnets by Partial Substitution of La and Ce Periode 2020 - 2023 Region Region Midtjylland Program Erhvervsforsker Fagområde Produktion, Materialer, Digitalisering og IKT Investering Percentage 100 Fondens investering 1,2 mio. Samlet budget 1,2 mio. Projektdeltagere Aarhus University, GRUNDFOS A/S Projektleder GRUNDFOS A/S Læs mere om projektet
Development of CRISPR-based drugs targeting MDR/XDR ‘high-risk clones’ of Pseudomonas aeruginosa	2020 - 2023	Erhvervsforsker
Development of CRISPR-based drugs targeting MDR/XDR ‘high-risk clones’ of Pseudomonas aeruginosa Periode 2020 - 2023 Region Region Hovedstaden Program Erhvervsforsker Fagområde Biotek, Medico og Sundhed Investering Percentage 64.05 Fondens investering 1,1 mio. Samlet budget 1,7 mio. Projektdeltagere Technical University of Denmark, SNIPR BIOME APS Projektleder SNIPR BIOME APS Læs mere om projektet
Development of electrical foot file PediCurve M.D.	2024 - 2024	Innobooster
Development of electrical foot file PediCurve M.D. Periode 2024 - 2024 Region Program Innobooster Fagområde Ikke defineret Investering Percentage 35 Fondens investering 479.238 Samlet budget 1,4 mio. Projektdeltagere The Curve ApS Projektleder Læs mere om projektet
Development of electrochemically deposited surfaces based on copper and silver with bactericidal effect	2016 - 2019	Erhvervsforsker
Development of electrochemically deposited surfaces based on copper and silver with bactericidal effect Periode 2016 - 2019 Region Region Hovedstaden Program Erhvervsforsker Fagområde Produktion, Materialer, Digitalisering og IKT Investering Percentage 43.14 Fondens investering 1,1 mio. Samlet budget 2,5 mio. Projektdeltagere Technical University of Denmark, ELPLATEK A/S AF 1995 Projektleder ELPLATEK A/S AF 1995 Læs mere om projektet